Homebiotech

biotech

AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022

AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022

December 19, 2022

James Flynn Joins ARCA biopharma Board of Directors

James Flynn Joins ARCA biopharma Board of Directors

December 19, 2022

RM LAW Announces Class Action Lawsuit Against Eiger Biopharmaceuticals, Inc.

RM LAW Announces Class Action Lawsuit Against Eiger Biopharmaceuticals, Inc.

December 19, 2022

Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis

Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis

December 19, 2022

Apellis (APLS) Files MAA for Pegcetacoplan in GA in Europe

Apellis (APLS) Files MAA for Pegcetacoplan in GA in Europe

December 19, 2022

ROSEN, A LEADING NATIONAL FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

ROSEN, A LEADING NATIONAL FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

December 19, 2022

CLASS ACTION UPDATE for SEDG, EIGR and UIS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

CLASS ACTION UPDATE for SEDG, EIGR and UIS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

December 19, 2022

Is Axonics (AXNX) Outperforming Other Medical Stocks This Year?

Is Axonics (AXNX) Outperforming Other Medical Stocks This Year?

December 19, 2022

Mustang Bio Provides CAR T Cell Therapy Portfolio Updates and 2023 Anticipated Milestones

Mustang Bio Provides CAR T Cell Therapy Portfolio Updates and 2023 Anticipated Milestones

December 19, 2022

Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors

Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors

December 19, 2022

« 1 … 8 9 10 11 12 … 558 »